Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific, Latin America, Africa and the Middle East.

Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific, Latin America, Africa and the Middle East.

Indicaton

Insomnia

Therapeutic indications

Type of product

Small molecule

Table

Phase

Marketed

You may also be interested in

Dimiracetam

Management of acute and chronic symptoms of chemotherapy-induced sensory peripheral neuropathy.

Phase II started

Small molecule therapeutic that aims to treat Alzheimer’s patients

Alzheimer’s disease

Discovery

nizubaglustat

Has the potential to treat multiple rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses, and Niemann-Pick type C disease (NPC).

Phase III started